Short Message System (SMS) for Caregivers of Suicidal Patients to Prevent Recidivism of Suicide Attempts (C-SIAM)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03069560|
Recruitment Status : Recruiting
First Posted : March 3, 2017
Last Update Posted : January 5, 2018
|Condition or disease||Intervention/treatment||Phase|
|Prevention of the Suicide||Device: SMS||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||15 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Short Message System (SMS) for Caregivers of Suicidal Patients to Prevent Recidivism of Suicide Attempts|
|Actual Study Start Date :||July 19, 2017|
|Estimated Primary Completion Date :||January 2018|
|Estimated Study Completion Date :||March 2018|
The patients will receive from the caregiver a first SMS 48 hours after their discharge from the hospital then a total of 4 messages : 48 hours, S1, S2, and S4.
SMS contact from the caregiver with patient after discharge in intervention group
- Measurement of the feasibility of the device by the patient according to a validated questionnaire [ Time Frame: 6 months ]The primary endpoint is the measurement of the feasibility of the device by the patient based on a validated questionnaire. This evaluation will take place during the medical interview that will close the study participation.
- The questionnaire measuring the feasibility for the caregiver of such a device [ Time Frame: 6 months ]A questionnaire will be provided to the caregiver to measure the feasibility of such a device
- Questionnaires on the acceptability of patients and caregivers in relation to the use of this type of monitoring device [ Time Frame: 6 months ]Acceptability questionnaires will be provided to patients and caregivers in relation to the use of this type of monitoring device
- Qualitative analysis of messages sent to patients during the study. [ Time Frame: 6 months ]A qualitative analysis of the messages addressed to the patients during the study will be carried out.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03069560
|Contact: Michel WALTER||02 98 01 51 57 ext +firstname.lastname@example.org|
|CHU de Brest||Recruiting|
|Brest, France, 29609|
|Contact: Jean-Michel WALTER, Professor email@example.com|